{"id":"NCT05032859","sponsor":"Organon and Co","briefTitle":"Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)","officialTitle":"A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Moderate to Severe Atopic Dermatitis in Children and Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-09-23","primaryCompletion":"2023-02-03","completion":"2023-02-08","firstPosted":"2021-09-02","resultsPosted":"2025-09-02","lastUpdate":"2025-09-02"},"enrollment":406,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Atopic Dermatitis"],"interventions":[{"type":"DRUG","name":"tapinarof cream, 1%","otherNames":[]},{"type":"DRUG","name":"vehicle cream","otherNames":[]}],"arms":[{"label":"tapinarof cream","type":"EXPERIMENTAL"},{"label":"vehicle cream","type":"PLACEBO_COMPARATOR"}],"summary":"This is a double-blind, randomized, vehicle controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% compared to vehicle control cream in pediatric and adult subjects with atopic dermatitis.","primaryOutcome":{"measure":"Percent of Subjects Who Have a Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) Score of Clear or Almost Clear (0 or 1) With a Minimum 2-grade Improvement From Baseline to Week 8. Analyses Were Done Using Multiple Imputation.","timeFrame":"Baseline to Week 8","effectByArm":[{"arm":"Tapinarof Cream","deltaMin":46.4,"sd":null},{"arm":"Vehicle Cream","deltaMin":18,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":13},"locations":{"siteCount":62,"countries":["United States","Canada"]},"refs":{"pmids":["38777187","40696240","40600584","39799945","39777610"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":271},"commonTop":["Folliculitis","Upper respiratory tract infection","Pyrexia","COVID-19","Nasopharyngitis"]}}